Longer-term effectiveness of a heterologous coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers in Brazil

OBJECTIVE: To compare the long-term vaccine effectiveness between those receiving viral vector [Oxford-AstraZeneca (ChAdOx1)] or inactivated viral (CoronaVac) primary series (2 doses) and those who received an mRNA booster (Pfizer/BioNTech) (the third dose) among healthcare workers (HCWs). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Marra, Alexandre R., Miraglia, João Luiz, Malheiro, Daniel Tavares, Guozhang, Yang, Teich, Vanessa Damazio, Victor, Elivane da Silva, Pinho, João Renato Rebello, Cypriano, Adriana, Vieira, Laura Wanderly, Polonio, Miria, Ornelas, Rafael Herrera, de Oliveira, Solange Miranda, Borges, Flavio Araujo, Oler, Silvia Cristina Cassiano, Ricardo, Victória Catharina Volpe, Maezato, Aline Miho, Callado, Gustavo Yano, Schettino, Guilherme de Paula Pinto, de Oliveira, Ketti Gleyzer, Santana, Rúbia Anita Ferraz, Malta, Fernanda de Mello, Amgarten, Deyvid, Boechat, Ana Laura, Kobayashi, Takaaki, Salinas, Jorge L., Edmond, Michael B., Rizzo, Luiz Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311693/
https://www.ncbi.nlm.nih.gov/pubmed/37396193
http://dx.doi.org/10.1017/ash.2023.173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311693/
https://www.ncbi.nlm.nih.gov/pubmed/37396193
http://dx.doi.org/10.1017/ash.2023.173

Ejemplares similares